A Billion Dollars, page-94

If that's the case then I'm in. Would love to see their holding post CR and compare it to now, very helpful thankyou.

Seems they have a huge amount of work ahead of them but I suspect they'll target the most economic early on and then continue to explore. How does that compare to other holders opinions?

Missed deadlines can be an annoyance and be a serious concern in some instances.. It doesnt seem that's the case here, its more likely that they're collating the data up to a certain point. Does that seem right?

Just so I'm up to speed - some assays due anytime now and then the release of a JORC sometime in Q2. Couple of exploration applications still in the process of getting approval but two just recently granted. Next CR not until end of year. Apart from the timeline concerns what are the other negatives?